Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 31Prostatic Neoplasms 13Breast Neoplasms 13Colorectal Neoplasms 12Hematologic Neoplasms 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lung Neoplasms 6Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Uterine Cervical Neoplasms 4Pancreatic Neoplasms 4Myasthenia Gravis 4Melanoma 4Lymphoma, Non-Hodgkin 4Leukemia, Myeloid, Acute 4Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Adenocarcinoma 4Pain 3Ovarian Neoplasms 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Hematopoietic and Lymphatic System Neoplasm 3Hematologic Diseases 3Glioma 3Gastrointestinal Neoplasms 3Carcinoma, Renal Cell 3Brain Neoplasms 3Anxiety Disorders 3Urinary Bladder Neoplasms 2

Interventions

Doxorubicin 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Gastric Cancer Peritoneal Metastases × 90 days × Clear all
NCT07517419 2026-04-08

PIPAC in Gastric Peritoneal Metastasis

Chinese University of Hong Kong

Phase 2 Enrolling by invitation
30 enrolled
Gastrointestinal

Gastric Cancer Peritoneal Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡